Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702808 | Urologic Oncology: Seminars and Original Investigations | 2016 | 8 Pages |
Abstract
High AGR is a strong independent predictor of long-term RFS and CSS in patients with BUC undergoing RC. Additionally, among patients with normal albumin (â¥40 g/l) levels, patients with higher globulin, but lower AGR have worse survival. The pretreatment AGR is an easily accessible and cheap to use for predicting mortality in patients with BUC treated by RC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jianye M.D., Yingbo M.D., Fangjian M.D., Zhi M.D., Yonghong M.D., Bin M.D., Dan Ph.D., Jin M.D., Jing M.D., Kun M.D., Yichuan M.D., Yuxin M.D., Leye M.D.,